Literature DB >> 29138295

Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology.

David J Hughes1,2, Christian Tiede3,4, Natalie Penswick3, Anna Ah-San Tang3,4, Chi H Trinh3,5, Upasana Mandal3,4, Katarzyna Z Zajac4, Thembaninskosi Gaule5, Gareth Howell3, Thomas A Edwards3,5, Jianxin Duan6, Eric Feyfant7, Michael J McPherson3,4,5, Darren C Tomlinson1,4,5, Adrian Whitehouse1,5.   

Abstract

Because protein-protein interactions underpin most biological processes, developing tools that target them to understand their function or to inform the development of therapeutics is an important task. SUMOylation is the posttranslational covalent attachment of proteins in the SUMO family (SUMO-1, SUMO-2, or SUMO-3), and it regulates numerous cellular pathways. SUMOylated proteins are recognized by proteins with SUMO-interaction motifs (SIMs) that facilitate noncovalent interactions with SUMO. We describe the use of the Affimer system of peptide display for the rapid isolation of synthetic binding proteins that inhibit SUMO-dependent protein-protein interactions mediated by SIMs both in vitro and in cells. Crucially, these synthetic proteins did not prevent SUMO conjugation either in vitro or in cell-based systems, enabling the specific analysis of SUMO-mediated protein-protein interactions. Furthermore, through structural analysis and molecular modeling, we explored the molecular mechanisms that may underlie their specificity in interfering with either SUMO-1-mediated interactions or interactions mediated by either SUMO-2 or SUMO-3. Not only will these reagents enable investigation of the biological roles of SUMOylation, but the Affimer technology used to generate these synthetic binding proteins could also be exploited to design or validate reagents or therapeutics that target other protein-protein interactions.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29138295      PMCID: PMC5777597          DOI: 10.1126/scisignal.aaj2005

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  57 in total

1.  Evidence for dynamically organized modularity in the yeast protein-protein interaction network.

Authors:  Jing-Dong J Han; Nicolas Bertin; Tong Hao; Debra S Goldberg; Gabriel F Berriz; Lan V Zhang; Denis Dupuy; Albertha J M Walhout; Michael E Cusick; Frederick P Roth; Marc Vidal
Journal:  Nature       Date:  2004-06-09       Impact factor: 49.962

2.  Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.

Authors:  Andrew T Namanja; Yi-Jia Li; Yang Su; Steven Wong; Jingjun Lu; Loren T Colson; Chenggang Wu; Shawn S C Li; Yuan Chen
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

3.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 4.  Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.

Authors:  H-M Shih; C-C Chang; H-Y Kuo; D-Y Lin
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

5.  Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.

Authors:  Anja Berndt; Heike Hofmann-Winkler; Nina Tavalai; Gabriele Hahn; Thomas Stamminger
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

6.  In vivo characterization of the properties of SUMO1-specific monobodies.

Authors:  Anja Berndt; Kevin A Wilkinson; Michaela J Heimann; Paul Bishop; Jeremy M Henley
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

7.  NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target.

Authors:  David J Hughes; Jennifer J Wood; Brian R Jackson; Belinda Baquero-Pérez; Adrian Whitehouse
Journal:  PLoS Pathog       Date:  2015-03-20       Impact factor: 6.823

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

Review 9.  Interplay between viruses and host sumoylation pathways.

Authors:  Roger D Everett; Chris Boutell; Benjamin G Hale
Journal:  Nat Rev Microbiol       Date:  2013-04-29       Impact factor: 60.633

10.  PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation.

Authors:  Katherine J Hands; Delphine Cuchet-Lourenco; Roger D Everett; Ronald T Hay
Journal:  J Cell Sci       Date:  2013-11-04       Impact factor: 5.285

View more
  12 in total

Review 1.  Visualizing ubiquitination in mammalian cells.

Authors:  Sjoerd Jl van Wijk; Simone Fulda; Ivan Dikic; Mike Heilemann
Journal:  EMBO Rep       Date:  2019-01-21       Impact factor: 8.807

2.  Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.

Authors:  Katherine J Kearney; Nikoletta Pechlivani; Rhodri King; Christian Tiede; Fladia Phoenix; Ramsah Cheah; Fraser L Macrae; Katie J Simmons; Iain W Manfield; Kerrie A Smith; Benjamin E J Spurgeon; Khalid M Naseem; Robert A S Ariens; Michael J McPherson; Darren C Tomlinson; Ramzi A Ajjan
Journal:  Blood       Date:  2018-12-13       Impact factor: 22.113

3.  RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site.

Authors:  Katarzyna Z Haza; Heather L Martin; Ajinkya Rao; Amy L Turner; Sophie E Saunders; Britta Petersen; Christian Tiede; Kevin Tipping; Anna A Tang; Modupe Ajayi; Thomas Taylor; Maia Harvey; Keri M Fishwick; Thomas L Adams; Thembaninkosi G Gaule; Chi H Trinh; Matthew Johnson; Alexander L Breeze; Thomas A Edwards; Michael J McPherson; Darren C Tomlinson
Journal:  Nat Commun       Date:  2021-06-30       Impact factor: 14.919

Review 4.  Natural product-informed exploration of chemical space to enable bioactive molecular discovery.

Authors:  Adam Nelson; George Karageorgis
Journal:  RSC Med Chem       Date:  2020-12-16

5.  POLArIS, a versatile probe for molecular orientation, revealed actin filaments associated with microtubule asters in early embryos.

Authors:  Ayana Sugizaki; Keisuke Sato; Kazuyoshi Chiba; Kenta Saito; Masahiko Kawagishi; Yuri Tomabechi; Shalin B Mehta; Hirokazu Ishii; Naoki Sakai; Mikako Shirouzu; Tomomi Tani; Sumio Terada
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 12.779

Review 6.  Advances in targeted degradation of endogenous proteins.

Authors:  Sascha Röth; Luke J Fulcher; Gopal P Sapkota
Journal:  Cell Mol Life Sci       Date:  2019-04-27       Impact factor: 9.261

7.  Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold.

Authors:  Matja Zalar; Sowmya Indrakumar; Colin W Levy; Richard B Tunnicliffe; Günther H J Peters; Alexander P Golovanov
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

Review 8.  Toxin Neutralization Using Alternative Binding Proteins.

Authors:  Timothy Patrick Jenkins; Thomas Fryer; Rasmus Ibsen Dehli; Jonas Arnold Jürgensen; Albert Fuglsang-Madsen; Sofie Føns; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

9.  Exploiting nanobodies and Affimers for superresolution imaging in light microscopy.

Authors:  Glenn Carrington; Darren Tomlinson; Michelle Peckham
Journal:  Mol Biol Cell       Date:  2019-10-15       Impact factor: 4.138

10.  Selection and characterisation of Affimers specific for CEA recognition.

Authors:  Shazana Hilda Shamsuddin; David G Jayne; Darren C Tomlinson; Michael J McPherson; Paul A Millner
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.